Stockscreener 앱 받기
1.51%
Amgen Inc 주식(AMGN)의 최신 뉴스
Dorato Capital Management Invests $1.58 Million in Amgen Inc. $AMGN - MarketBeat
Aberdeen Group plc Acquires 27,107 Shares of Amgen Inc. $AMGN - MarketBeat
How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen’s (AMGN) Risk‑Reward Profile - Yahoo Finance
Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer - BioPharma APAC
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Australia
Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory - The Motley Fool
Amgen's Diversification Continues To Pay Off, RBC Says - Moomoo
Turning Up the Volume on IgG4-RD Awareness and Diagnosis - Amgen
Amgen Terminates Early-Stage AMG 378 Study: What Investors Should Watch Next - TipRanks
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now? - Yahoo Finance
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $390 - Moomoo
HF Advisory Group LLC Buys 7,548 Shares of Amgen Inc. $AMGN - MarketBeat
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 - GlobeNewswire
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate - Yahoo Finance Singapore
Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: ReportAmgen (NASDAQ:AM - Benzinga
Zai Lab (09688.HK) Enters Global Collaboration with Amgen (AMGN.US) to Explore Novel ADC and BiTE Combination Therapy - AASTOCKS.com
Will FDA Tavneos Safety Scrutiny and New Lung Cancer Combo Trial Change Amgen's (AMGN) Narrative? - simplywall.st
Amgen Inc. Stock: Biotech Leader's Strategic Pipeline and Oncology Focus Drive Long-Term Investor Va - AD HOC NEWS
Zai Lab gains after Amgen clinical trial deal (ZLAB:NASDAQ) - Seeking Alpha
Here's What You Need to Know about Amgen, Inc's AMG-145 - Yahoo
Amgen (AMGN) and Zai Lab Partner for Lung Cancer Treatment Study - GuruFocus
Once the center of a $3.7 billion buyout, drug blamed for eight deaths draws FDA alert - The Business Journals
Zai Lab Limited and Amgen Inc Enter Global Clinical Trial Collaboration Agreement - MarketScreener
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $432 - Moomoo
A two-drug small cell lung cancer trial pairs Amgen with Zai Lab - Stock Titan
Highline Wealth Partners LLC Sells 4,004 Shares of Amgen Inc. $AMGN - MarketBeat
Nisa Investment Advisors LLC Has $55.22 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat
Amgen Inc. $AMGN Shares Bought by Moody Lynn & Lieberson LLC - MarketBeat
Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN
Sarcopenia Treatments Market Is Going to Boom | AbbVie • Amgen • Pfizer • Novartis - openpr.com
Amgen Inc. (NASDAQ:AMGN) Given Average Rating of "Hold" by Analysts - MarketBeat
US FDA warns of liver injury cases tied to Amgen's rare disease drug - Reuters
FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos UseAmgen (NASDAQ:AMGN) - Benzinga
FDA Says Amgen’s Tavneos Linked to Liver Injuries, Deaths - WSJ
FDA Flags Serious Liver Risks with Amgen's Tavneos (AMGN) - GuruFocus
FDA issues warning for Amgen's Tavneos following serious liver injury cases - Seeking Alpha
Amgen CEO Bob Bradway's 2025 Letter to Shareholders - Amgen
Amgen’s Tavneos Associated With Liver Injury, Deaths, FDA Says - Bloomberg.com
Amgen price breaches upside trend lineForecast tody31-03-2026 - Economies.com
Amgen Inc. $AMGN Shares Purchased by Hofer & Associates. Inc - MarketBeat
The Zacks Analyst Blog Roche Holding, AT&T and Amgen - The Globe and Mail
Mn Services Vermogensbeheer B.V. Acquires 3,327 Shares of Amgen Inc. $AMGN - MarketBeat
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN - MarketBeat
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN - MarketBeat
Top Stock Reports for Roche, AT&T & Amgen - The Globe and Mail
Jefferies reiterates Amgen stock Hold rating on TED trial data - Investing.com
Amgen Inc. Stock: Steady Biotech Leader with Strong Dividend Yield and Growth Guidance Amid Analyst - AD HOC NEWS
Amgen’s Repatha Slashes Heart Event Risk in Early‑Stage Patients - Citeline News & Insights
Amgen (AMGN) Stock Up Since Jim Cramer Said “You Could Do a Lot Worse Than Amgen” - Insider Monkey
R.H. Dinel Investment Counsel Inc. Has $6.33 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Exchange Traded Concepts LLC Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Wealthcare Advisory Partners LLC - MarketBeat
Nova R Wealth Inc. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen’s Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate - simplywall.st
Amgen's Repatha Cuts Risk Of First Major Cardiovascular Event By 31% In High-Risk Patients - TradingView
In diabetes patients, Repatha cut first major heart event risk 31% - Stock Titan
Here is what to know beyond why Amgen Inc. (AMGN) is a trending stock - MSN
Amgen Inc. stock underperforms Friday when compared to competitors - MarketWatch
0.42%
1.37%
자본화:
|
볼륨(24시간):